These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 9589358)

  • 1. Effect of retinoic acid on HPV titration and colposcopic changes in Korean patients with dysplasia of the uterine cervix.
    Ahn WS; Lee JM; Namkoong SE; Lee HY; Kim SJ
    J Cell Biochem Suppl; 1997; 28-29():133-9. PubMed ID: 9589358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
    Apgar BS; Brotzman G
    Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
    Layfield LJ; Qureshi MN
    Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
    Fletcher AH; Wilkinson EJ; Knapik JA
    J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology.
    Bollen LJ; Tjong-A-Hung SP; van der Velden J; Mol BW; ten Kate FW; ter Schegget J; Bleker OP
    Gynecol Oncol; 1999 Feb; 72(2):199-201. PubMed ID: 10021301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus.
    Barzon L; Pizzighella S; Corti L; Mengoli C; Palù G
    J Med Virol; 2002 Jul; 67(3):401-5. PubMed ID: 12116034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HPV testing in patients with possible high-grade cervical cytology.
    Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
    J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of minor degrees of cervical dysplasia associated with the human papilloma virus.
    Carmichael JA
    Yale J Biol Med; 1991; 64(6):591-7. PubMed ID: 1667239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and treatment of dysplasia of the uterine cervix].
    Jobo T; Wakita K; Sasaki N; Hayashi R; Morisawa T; Tsunoda S; Kuramoto H; Arai M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1592-7. PubMed ID: 2730054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphotometric nuclear DNA analysis in cervical dysplasia of the uterine cervix: its relation to the progression to malignancy and regression to normalcy.
    Kashyap V; Das DK; Luthra UK
    Neoplasma; 1990; 37(5):497-500. PubMed ID: 2234211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
    Meyskens FL; Surwit E; Moon TE; Childers JM; Davis JR; Dorr RT; Johnson CS; Alberts DS
    J Natl Cancer Inst; 1994 Apr; 86(7):539-43. PubMed ID: 8133537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colposcopy in the management of cervical dysplasia.
    Kuroshima Y; Shinozuka T; Sahashi T; Shinohara M; Fujii A
    Tokai J Exp Clin Med; 1984 Dec; 9(5-6):371-8. PubMed ID: 6545482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy.
    Weiner SA; Surwit EA; Graham VE; Meyskens FL
    Invest New Drugs; 1986; 4(3):241-4. PubMed ID: 3818228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proposal for the treatment of cervix dysplasia with immunomodulators].
    Serra GE; Gustavino C; Serra Cervetti GG
    Minerva Ginecol; 1992; 44(1-2):15-8. PubMed ID: 1508378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap.
    Graham V; Surwit ES; Weiner S; Meyskens FL
    West J Med; 1986 Aug; 145(2):192-5. PubMed ID: 3765597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment results of liquid nitrogen cryotherapy on selected pathologic changes of the uterine cervix.
    Kourounis G; Iatrakis G; Diakakis I; Sakellaropoulos G; Ladopoulos I; Prapa Z
    Clin Exp Obstet Gynecol; 1999; 26(2):115. PubMed ID: 10459454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with topical tretinoin in the treatment of cervical dysplasia.
    Meyskens FL; Surwit ES
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):826-9. PubMed ID: 3534021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.